alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with MS (Multiple Sclerosis) in 3 studies
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Loría, F | 1 |
Petrosino, S | 1 |
Hernangómez, M | 1 |
Mestre, L | 1 |
Spagnolo, A | 1 |
Correa, F | 1 |
Di Marzo, V | 1 |
Docagne, F | 1 |
Guaza, C | 1 |
Nisticò, R | 1 |
Mango, D | 1 |
Mandolesi, G | 1 |
Piccinin, S | 1 |
Berretta, N | 1 |
Pignatelli, M | 1 |
Feligioni, M | 1 |
Musella, A | 1 |
Gentile, A | 1 |
Mori, F | 1 |
Bernardi, G | 1 |
Nicoletti, F | 1 |
Mercuri, NB | 1 |
Centonze, D | 1 |
Bolton, C | 1 |
Paul, C | 1 |
1 review available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and MS (Multiple Sclerosis)
Article | Year |
---|---|
Glutamate receptors in neuroinflammatory demyelinating disease.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Demyelinating Diseases; Encephalo | 2006 |
2 other studies available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and MS (Multiple Sclerosis)
Article | Year |
---|---|
An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Arachidonic Acids; Astrocytes; Ca | 2010 |
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; CA1 Region, Hippocampal; Cell Lin | 2013 |